Farudodstat clinical trials
Also written ASLAN003.
How each study uses farudodstat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the farudodstat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 4
ASLAN Pharmaceuticals (4)
Studies
Open first, then newest update. How each study uses farudodstat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata ParticipantsRecruitingPhase 2ASLAN PharmaceuticalsNCT05865041Written as FarudodstatHow we know
- A Dose Optimisation Study of ASLAN003 in Acute Myeloid LeukemiaCompletedPhase 2ASLAN PharmaceuticalsNCT03451084Written as ASLAN003How we know
- Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003CompletedPhase 1ASLAN PharmaceuticalsNCT01992367Written as ASLAN003 ACTIVEHow we know
- A Phase 1, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASLAN003 in Healthy Elderly SubjectsCompletedPhase 1ASLAN PharmaceuticalsNCT02342652Written as ASLAN003How we know
Codes
What other systems call farudodstat · ClinicalTrials.gg INT016823
- UNII (FDA) I58WE41H6XFARUDODSTATOne source FDA
- NCI Thesaurus C156777FarudodstatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | I58WE41H6X | FARUDODSTAT | One source FDA |
| NCI Thesaurus | C156777 | Farudodstat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.